Quidel Corp. Reports Strong First Quarter Earnings in Fiscal Year 1996
Quidel Corp., a leading developer and marketer of rapid diagnostic tests, announced a 61 percent increase in net product sales for the first quarter of fiscal year 1996, driven by growth in international sales and the successful integration of Pacific Biotech, a company acquired in the fourth quarter of fiscal 1995. The company's domestic sales also showed a significant increase, led by sales of pregnancy and infectious disease detection products in the doctor's office market and the consumer market.
Key Takeaways:
- Quidel's net product sales for the first quarter of fiscal year 1996 totaled $8.5 million, a 61 percent increase over the prior year's quarterly sales of $5.3 million.
- Domestic sales increased 35 percent, driven by growth in the doctor's office market and consumer market sales of pregnancy and ovulation tests.
- International sales soared 120 percent, primarily driven by growth in Quidel's European subsidiaries.
- The company's gross profit margin improved significantly to 54 percent from 44 percent a year ago, reflecting the higher margin products under Quidel's brand names and increased factory utilization.
- Quidel's net income for the first quarter was $17,000, or break-even per share ($.00 per share), compared to a net loss of $1.7 million, or ($.09) per share in the prior year's three-month period.
- The company's president and CEO, Steven T. Frankel, attributed the success to the successful integration of Pacific Biotech and the rapid consolidation of redundant expenses.
- Quidel continues to strengthen sales of its product lines on a worldwide basis and is encouraged by the timely FDA review process for its QuickVue(R) Chlamydia Test.
Statistics:
- Quidel's net product sales for the first quarter totaled $8.5 million.
- The company's domestic sales increased by 35 percent.
- International sales increased by 120 percent.
- The company's gross profit margin improved to 54 percent.
- Quidel's net income for the first quarter was $17,000.
Sources:
- QUIDEL Corp. press release, July 31, 1995.
- QUIDEL Corp. investor relations, July 31, 1995.
- PR Newswire, July 31, 1995.